✦ LIBER ✦

Where next in immunotherapy for melanoma?

Book ID: 120876291
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 1997
Weight: 158 KB
Volume: 1093
Category: Article
ISSN: 1173-8324
DOI: 10.1007/BF03315197

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Next Generation of Immunotherapy for Mel

Next Generation of Immunotherapy for Melanoma

✍ Kirkwood, J. M.; Tarhini, A. A.; Panelli, M. C.; Moschos, S. J.; Zarour, H. M.; 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 352 KB

Immunotherapy for the Management of Adva

Immunotherapy for the Management of Advanced Melanoma: The Next Steps

✍ Zikich, Dragoslav; Schachter, Jacob; Besser, Michal J. 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 296 KB

Immunotherapy for melanoma

✍ Lacy, Katie E; Karagiannis, Sophia N; Nestle, Frank O 📂 Article 📅 2012 🏛 Expert Reviews 🌐 English ⚖ 714 KB

Immunotherapy for melanoma

✍ Ian Komenaka; Heidi Hoerig; Howard L Kaufman 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 306 KB

Progress in immunotherapy for melanoma?

✍ Ezzie Hutchinson 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 57 KB

Immunotherapy for metastatic melanoma

✍ Christopher R. Zito; Harriet M. Kluger 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

## Abstract Melanoma has traditionally been considered an immunogenic tumor. A number of approaches have been studied for enhancement of antitumor immunity. The first cytokine approved for the treatment of metastatic melanoma, interleukin‐2, has resulted in prolonged responses in a small subset of